首页 | 本学科首页   官方微博 | 高级检索  
     

CHST13抑制肝癌细胞侵袭能力的研究
引用本文:李艳平,刘有训,马红叶,王宁,张旭. CHST13抑制肝癌细胞侵袭能力的研究[J]. 国际肿瘤学杂志, 2014, 41(4): 314-318
作者姓名:李艳平  刘有训  马红叶  王宁  张旭
作者单位:李艳平 (116044,大连医科大学检验医学院); 刘有训 (116044,大连医科大学检验医学院); 马红叶 (116044,大连医科大学检验医学院); 王宁 (116044,大连医科大学检验医学院); 张旭 (116044,大连医科大学检验医学院);
摘    要:目的 通过研究磺基转移酶CHST13在人肝癌高转移细胞株MHCC97-H和人肝癌低转移细胞株MHCC97-L中的差异表达,明确其与肝癌转移的相关性,从而证实肝癌转移诊断及抗肿瘤治疗新靶点.方法 采用实时PCR、Western blot分析磺基转移酶CHST13在人肝癌高、低转移细胞株的差异表达,通过RNA干扰技术干预CHST13基因,检测干扰前后MHCC97-L细胞的体外侵袭力及体内成瘤性.结果 CHST13在人肝癌高、低转移细胞株中表达具有明显差异;下调MHCC97-L细胞中CHST13基因表达后,穿过基底膜的细胞数量[(30±3)个]明显多于未处理组[(14±2)个],体外侵袭力显著增强(t=2.8,P=0.005);相对于正常细胞[(0.5±0.06)g],干扰后细胞的肿瘤平均重量[(0.9±0.10)g]明显增大,体内成瘤性明显提高(t=2.5,P=0.01).结论 磺基转移酶CHST13与肝癌细胞的侵袭、成瘤性密切相关,其有望成为肝癌临床治疗的新靶点.

关 键 词:磺基转移酶类  癌,肝细胞  肿瘤转移

CHST13 inhibits the invasive property of human hepatocellular carcinoma cells
Li Yanping,Liu Youxun,Ma Hongye,Wang Ning,Zhang Xu. CHST13 inhibits the invasive property of human hepatocellular carcinoma cells[J]. Journal of International Oncology, 2014, 41(4): 314-318
Authors:Li Yanping  Liu Youxun  Ma Hongye  Wang Ning  Zhang Xu
Affiliation:. College of Medical Laboratory, Dalian Medical University, Dalian 116044, China
Abstract:Objective To clarify the association between chondroitin-4-O-sulfotransferase-3 (CHST13) and hepatoma metastasis by the research of differential expression of CHST13 in MHCC97-H and MHCC97-L human hepatocarcinoma cell lines, which have high and low metastatic potential, respectively, and to confirm novel target of hepatoma metastasis and anti-tumor therapy. Methods The differential expressions of CHST13 in MHCC97-H and MHCC97-L human hepatocarcinoma cell lines were analyzed by real-time PCR, Western blot. CHST13 was silenced using RNA interference approach to detect the invasive ability in vitro and tumorigenicity in vivo in MHCC97-L cells. Results The expression of CHST13 was different in MHCC97-L cells, as compared to those in MHCC97-H cells. Knockdown of CHST13 expression enhanced MHCC97-L ceils invasion and tumorigenicity both in vitro (t = 2.8, P = 0. 005 ) and in vivo ( t = 2.5, P = 0.01 ). The quantity of cells which crossed basement membrane increased [ (30 ± 3 ) : ( 14 ± 2) ], and the average weight of tumor increased [ (0.9 ± 0. 10) g : (0.5 ± 0.06 ) g ]. Conclusion The differential expressions of CHST13 in human hepatocarcinoma cell lines correlate with tumor invasion and tumorigenicity, and it is expected to be a novel target for the treatment of hepatocellular carcinoma.
Keywords:Sulfotransferases  Carcinoma, hepatocellular  Neoplasm metastasis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号